This page provides educational resources, events, news and products related to anticancer therapies. Content will cover aspects from chemo- and radiotherapies, to cell-based treatments and cancer vaccines.
Anticancer Therapies – Highlights
Modern Milestones in Cancer Research
Tremendous progress has been made in the cancer research field over the past 20 years. This infographic highlights 10 major milestones since the year 2000.
Cancer Drug Discovery: A Molecular Journey to Targeted Treatment
Cancer drug discovery has made great advances since its earliest steps. Cytotoxic drugs affect healthy cells, as well as the tumor, and thus give rise to a multitude of side effects. To counter this, the focus has shifted to targeted approaches that exploit molecular characteristics that are unique to the tumor.
New Advances in Cancer Drug Discovery
Download this listicle to discover new biological insights, explore various drug modalities and uncover novel drug combinations.
Drug Targeting “Stressed” Cancer Cells Shows Promise in Trial
In a clinical trial, a new drug prevented cancer growth in terminally ill patients, with 70% of those who received the medicine becoming stable after six weeks.
Physical Activity May Prevent Colon Cancer Returning
New research has found that physical activity can prevent, and not just delay, cancer recurrence in patients previously treated for colon cancer.
Nanotechnology Could Aid Drug Delivery for Lymphedema
By using nanotechnology to repair the pumping action of lymphatic vessels, Georgia Institute of Technology researchers have developed a unique approach to treating lymphedema.
Improved Bone Tumor Model Boosts Search for Therapies
Researchers have developed and used an upgraded tumor model that mimics bone to find that the body’s immune response can make tumor cells more resistant to chemotherapy.
SonALAsense Announces Completion of First Cohort in Phase 2 Study of Sonodynamic Therapy for Recurrent Glioblastoma
SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.
Terumo Blood and Cell Technologies’ Platelet Pooling Set Cleared by FDA
Terumo Blood and Cell Technologies has announced US Food and Drug Administration clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days.
Akamis Bio, Parker Institute for Cancer Immunotherapy and Cancer Research Institute Expand Partnership
Akamis Bio has announced an expansion of its ongoing partnership with the Parker Institute for Cancer Immunotherapy to include a clinical collaboration with the Cancer Research Institute that will focus on advancing novel treatments for pancreatic cancer.
Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.